My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    PLoS Clin Trials. 2006 Dec 22;1(8):e41.

    The suspension of treatments in ADAPT: concerns beyond the cardiovascular safety of celecoxib or naproxen.

    Breitner JC, Martin BK, Meinert CL.

    Comment on:

    PMID: 17192795 [PubMed]

    PMCID: 1713263

    Publication Types

    Publication Types:

    LinkOut - more resources

    Full Text Sources:

    Supplemental Content

    Click here to read Click here to read

    Related articles

    Cited by 1 PubMed Central article

    Patient drug information

    • Naproxen (Aleve®, Anaprox®, Anaprox® DS, ...)

      Prescription naproxen is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swellin...

    • Celecoxib (Celebrex®)

      Celecoxib is used to relieve pain, tenderness, swelling and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints), rheumatoid arthritis (arthritis caused by swelling of the lini...

    • Source: AHFS Consumer Medication Information

    All links from this record

    • Related Articles

      Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

    • Free in PMC

      Free full text articles in PMC

    • Cited in PMC

      Full-text articles in the PubMed Central Database that cite the current articles.

    Recent activity